Branded Rx Drug Prices are a Heavy Tax on the American People
Bruce Willard Barren on LinkedIn • 3 min read
By Bruce WD Barren
Editor’s Note: Economist Bruce WD Barren is Chairman of The EMCO/ Hanover Group. He is a regular contributor to Live Trading News.
While prices for common generic drugs have dropped by 37% since 2014, branded drug prices have increased by over 60%.
Here’s where the problem lies for that is what physicians are recommending, not generics but prescription drugs, especially the cost of lifesaving medications that millions of Americans, especially seniors, must rely on each day.
To me, it is time to focus on some basic needs of the American people and drug prescription costs is just one of them.
Finally, our President, using his authority under his Executive Orders, has chosen to focus on this field too.
Congress should had done it years ago, they should learn to serve us, not themselves.